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Abstract
Scd6, a yeast homologue of human RAP55, is a component of messenger ribonucleopro-
teins (mRNPs) that repress translation by binding to translation initiation factors, and also is
a decapping activator along with the binding partners Edc3 and Dhh1. Herein, we report
that Scd6 is a substrate of the intrinsic protein arginine methyltransferase, Hmt1, in budding
yeast Saccharomyces cerevisiae. Mass spectrometric analysis revealed that several argi-
nine residues within the Scd6 RGG motif, which is important for mRNA binding, were meth-
ylated in Hmt1 dependent manner. Under stress conditions such as glucose starvation,
Scd6 localized to cytoplasmic processing bodies (P-bodies) wherein translationally
repressed mRNPs and untranslated mRNAs accumulate. Localization of Scd6 to P-bodies
was impaired in hmt1 deletion mutant and in the presence of methylation-deficient substitu-
tion of Scd6. In addition, deletion of scd6 and dhh1 led to severe synthetic growth defect at
high temperature. Methylation-deficient mutation of Scd6 suppressed the phenotypic
defects of scd6 dhh1 double mutant, whereas methylation-mimic mutation did not, suggest-
ing that the arginine methylation might negatively regulate Scd6 function relating to Dhh1.
Therefore, the present data suggest that Hmt1-based arginine methylation is required for
Scd6 localization and function.
Introduction
Messenger ribonucleoprotein (mRNP) complexes comprise transcripts and RNA-binding pro-
teins (RBPs) and regulate gene expression. The lifecycle of mRNP includes mRNA transcrip-
tion, splicing, transport and localization, translation, and degradation. However, the ensuing
gene regulatorymechanisms have not been clarified in the analyses of compositions and kinet-
ics of mRNP complexes at each of these steps [1]. In Saccharomyces cerevisiae (S. cerevisiae),
regulators of RNA turnover and translation play essential roles in basal mRNA expression lev-
els under conditions of environmental stimulation. Regulatory pathways of cytoplasmic RNA
turnover include decapping by Dcp1/Dcp2 decapping complexes followed by 50–30 degradation
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by exonuclease Xrn1, and 30–50 degradation by exosome complexes [2–5]. Several studies have
focused on mechanisms that regulate translation initiation at the step in which the recruitment
of eIF4G/eIF4E cap-binding complexes occurs. These investigations revealed a competition
between translation initiation and decapping [6–9]. Moreover, replacement of initiation factors
by decapping enzymes requires other RBPs, which are referred to as decapping activators. Sev-
eral decapping activators such as Dhh1, Scd6, Stm1, and Pat1 were shown to repress translation
initiation, thereby enhancing the decapping processes [6, 8, 10]. However, it remains unclear
how functions and interactions of these RBPs are regulated.
Actively translating mRNPs associate with polysomes to initiate translation. Various stress
conditions, such as glucose starvation and severe heat shock, induce phase transitions of these
mRNPs toward the non-translating state and lead to assembly of most mRNPs into cyto-
plasmic foci such as processing-bodies (P-bodies) and stress granules (SGs) [11]. Proteins
required for active translation are found in SGs, whereas P-bodies include protein factors for
mRNA decay machinery such as Dcp1/2, Dhh1, Edc3, and Scd6, suggesting functional diver-
sity of these granules as sites of mRNA storage and mRNA degradation [11]. However, mRNA
decay occurs without the formation of large P-bodies [12], and P-body core components have
been colocalizedwith various molecules that are involved in biological processes such as DNA
replication and PKA signaling [13, 14]. Hence, knowledge of the activities of P-body compo-
nents may clarify the physiological functions and kinetics of P-bodies.
Scd6 was originally identified as a multicopy suppressor of clathrin deficiency [15] and a
decapping component of mRNPs, as indicated by competition with Edc3 to induce decapping
enzymes such as Dcp1/2 [16]. Recently, enhanced decapping activity of Scd6 was related to
repression of translation initiation through binding to eIF4G [8, 10]. Scd6 and its homologues
are highly conserved in eukaryotes, these proteins contain conservedN-terminal Lsm domains,
central FDF motifs, and C-terminal RGG (arginine–glycine–glycine) motifs, which are
required for the translation repressing functions of yeast Scd6 [17]. TheD.melanogaster homo-
logue Tral has been shown to interact directly with the conservedRNA helicase DDX6, which
is known as Dhh1 in yeast [18]. It has been reported that Dhh1 holds decapping and transla-
tion repression functions and is localized to P-bodies [6, 10, 18]. However, details of the inter-
actions of Dhh1 and Scd6 and the mechanisms that regulate functions and locations of these
P-body components remain unclear.
Previous studies have shown that proteins containing the RGG box are common substrates
of protein arginine methyltransferases (PRMTs) [19, 20]. Specifically, arginine residues of
RGG boxes can bemonomethylated or dimethylated. In particular, type I PRMTs catalyze the
formation of monomethylarginines (MMAs) or asymmetric-dimethylarginines (aDMAs),
whereas type II PRMTs catalyze the formation of symmetric-dimethylarginines (sDMAs) [21].
Heterogeneous nuclear ribonucleoproteins (hnRNPs) containing N-terminal RNA-binding
motifs in conjunction with RGG repeats are major substrates of PRMT1 in yeast and mamma-
lian cells [22]. Recently, arginine methylation has been shown to mediate RNA–protein, DNA–
protein, and protein–protein interactions [23, 24], and S. cerevisiaeHmt1 was identified as the
major type I PRMT [25]. Argininemethylation by PRMT1 is critical for the localization of the
hRAP55, Scd6 homologue in mammalian cells [26]. Similarly, Hmt1-mediated methylation of
arginine residues in several RBPs, such as Npl3 in budding yeast, regulates protein localization
and function [27].
In this study, we investigated protein partners of Scd6, and demonstrated associations of
Scd6 and Hmt1. Several arginine residues in RGGmotifs of Scd6 were methylated in a
Hmt1-dependent manner. Moreover, defects in arginine methylation of Scd6 in hmt1mutant
cells impaired Scd6-targeting to foci that form under conditions of glucose starvation. How-
ever, neither P-body formation nor targeting defects in components of P-bodies were
Hmt1 Methylates Scd6
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significantly perturbed.We also revealed overlapping functions of Scd6 and Dhh1 that are
required for P-body formation and cell growth. Moreover, arginine methylation had no effect
on cell growth or P-body formation defects in scd6 dhh1 double mutant cells. However, similar
cell growth was not observed at high temperatures, suggesting possible stress-dependent regu-
lation of Scd6 post-translational modification.
Materials and Methods
Strains, plasmids, and general methods
Escherichia coli DH5α was used for DNA manipulations and the present yeast strains and plas-
mids are described in S1 and S2 Tables. Cells were grown in yeast extract-peptone dextrose
(YPD), synthetic complete medium (SC), and synthetic minimal medium (SD), and in SC
media lacking either amino acids or other nutrients (SC–Ura, SC lacking uracil). General pro-
cedures were performed as describedpreviously in “Methods in yeast genetics” [28].
Gene deletion and protein tagging
Gene disruption and insertionwere performed using PCR-based gene replacement, as
describedpreviously [29, 30].
Yeast two-hybrid assays
PJ69-4A cells harboring pGBD-SCD6were transformed using the yeast two-hybrid library.
Transformants were then plated on SC-Leu-Trp plates and were incubated at 30°C for 4 days.
Plates were replica plated onto SC-Leu-Trp-His plates, SC-Leu-Trp-His plates containing
1-mM 3-aminotriazole (3-AT), and SC-Leu-Trp-Ade plates, and were incubated at 30°C for 3
days. Twenty-three transformants showed the His+ Ade+ phenotype, and corresponding
library plasmids were isolated from transformants, and were reassessed for interactions with
Scd6. Insert DNAs were sequenced.
To confirm the interactions of Scd6 and Hmt1 that were identified in two-hybrid screening
analyses, pGAD-c1-Hmt1 was constructed and used as a prey vector. PJ69-4A cells were then
co-transformedwith pGBD-c1 or pGBD-c1-Scd6with either pGAD-c1 or pGAD-c1-Hmt1,
and transformants were then spotted onto SC-Leu-Trp (WL), SC-Leu-Trp-His (WLH), and
SC-Leu-Trp-His (WLH) plates containing 1 mM 3-AT and were incubated for 3 days at 30°C.
Western blot analysis
Samples were loaded onto SDS-PAGE or NU-PAGE gels and were then electroblotted onto
Immobilon™ polyvinylidene difluoridemembranes (Merck Millipore, USA). Blots were blocked
for 1 h at room temperature with TBS-M buffer containing 20 mM Tris-HCl (pH 7.5), 150
mMNaCl, and 5% non-fat drymilk, and were then incubated with 1:1,000-diluted primary
antibodies in TBS-M buffer overnight at 4°C. After three final washes with TBS buffer contain-
ing 20 mM Tris-HCl (pH 7.5) and 150 mMNaCl, blots were incubated with secondary anti-
bodies, and were developed using enhanced chemiluminescencedetection kits (Merck
Millipore, USA).
Immunoprecipitation of Scd6Flag
Cells were grown in SC-Ura medium at 30°C to mid-log-phase and were harvested by centrifu-
gation. The cells were then resuspended in XT buffer containing 50 mMHEPES-KOH,
(pH 7.3), 20 mM potassium acetate, 2 mM EDTA, 0.1% Triton X-100, 5% glycerol protease
inhibitors, phenylmethylsulfonyl fluoride (PMSF), aprotinin, and leupeptin. Glass beads were
Hmt1 Methylates Scd6
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then added and cells were broken by rigorous vortexing at 4°C (4 times at 3,500 rpm for 30 s).
Lysates were then centrifuged for 10 min at 15,000 g and supernatants were collected. Extracts
were incubated with or without 200 μg/mL RNase A (Wako Pure Chemical Industries, Ltd.,
Japan) at room temperature for 30 min prior to immunoprecipitation.
To immunoprecipitate Scd6Flag, extracts were incubated with anti-Flag antibody coupled
to protein G-Sepharose beads (Sigma Aldrich, USA) for 30 min at 4°C. Scd6Flag-boundbeads
were then washed three times in XT buffer, and the boundmaterial was eluted with elution
buffer containing 0.1 mg/mL Flag peptide in XT buffer for 10 min at 4°C. Samples were sub-
jected to SDS-PAGE followed by colloidal Coomasie blue staining (Thermo Fisher Scientific).
RNA was isolated from immunopreciptated samples using RNeasy Mini kit (Qiagen) and sub-
jected to UREA-PAGE followed by SYBR-Gold staining (Life Technologies).
Protein purification and GST pull down assays
GST- and His6- fusion proteins were purified from E. coli strain BL21 (DE3) using glutathione-
sepharose beads (GE) and Ni-NTA agarose beads (Novagen), respectively. GST or
GST-Scd6-bound beads were then resuspended in HB buffer containing PBS, 0.5% Tween20, 5
mMMgCl2, 5 mM 2-mercaptoethanol, 1 mM PMSF, and a protease inhibitor cocktail (Com-
plete EDTA-free, Sigma Aldrich, USA). His6-Hmt1 was then eluted from Ni-NTA agarose
beads using a high concentration of imidazole. Proteins were dialyzed and concentrated using
Amicon Ultra-2-30K (Merck Millipore Ltd.).
His6-Hmt1 was incubated with GST or GST-Scd6 immobilized on beads for 3 h at 4°C.
After washing 5 times with PBS, beads were boiled in SDS sample buffer and samples were
then subjected to SDS-PAGE, followed by staining with Coomassie Brilliant Blue and immuno-
blotting with anti-His antibody (Sigma Aldrich, USA).
Microscopy
Cells were cultured until they reached an OD600 of approximately 0.6 in appropriate SC
medium. Cells were then collected, washed twice in fresh SCmediumwith or without 2% glu-
cose, and were then resuspended in fresh SCmediumwith or without glucose followed by incu-
bation at 30°C for 20 min. Cells were harvested, washed again and immediately examined for
granule formation using a Keyence BZ-X700 microscope (Keyence Corporation, Japan) at
room temperature. Experiments were performed a minimum of three times. Fluorescence
images were processed and analyzed for numbers of cells with foci formation and signal inten-
sities. More than 200 cells were counted and percentages of cells with foci formation were cal-
culated. Fluorescence intensities along 5- μm lines were measured using the linescan function
in MetaMorph software (Molecular Devices,USA) and averages of more than 10 foci from
each observationwere fitted to a Gaussian distribution.
Tandem mass spectrometry (arginine methylation mapping)
Scd6Flag was immunopurified as described above and was then subjected to SDS-PAGE and
stained using Colloidal Blue Staining Kits (Thermo Fisher Scientific, CA, USA). Gel bands con-
taining Scd6-Flag were excised and subjected to in-gel digestion with Chymotrypsin (Sequenc-
ing Grade, Promega). The resulting peptides were analyzed using a nanoflow LC-MS/MS
system with LTQ-Orbitrap hybrid mass spectrometer (model XL, Thermo Fisher Scientific,
CA, USA) as described elsewhere [31] with somemodifications. The peptidemixture was sepa-
rated using reverse phase chromatography with a 0%–40% gradient of acetonitrile containing
0.1% formic acid over 80 min at a flow rate of 100 nl/min using a Mightysil-RP-18 (3 μm parti-
cle, Kanto Chemical, Osaka, Japan) fritless column (45 mm × 0.150 mm i.d.). Eluted peptides
Hmt1 Methylates Scd6
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were sprayed directly into a LTQ-Orbitrap hybrid mass spectrometer and raw data were
acquired using Xcalibur version 2.0.7 (Thermo Fisher Scientific,USA) and were then converted
to MGF files using Proteome Discoverer version 1.3 software (Thermo Fisher Scientific).Data-
base searches were performed using MASCOT version 2.2.07 software and the Uniprot S. cere-
visiae (strain ATCC 204508/S288c) database with the following parameters: fixed
modification, carbamidemethyl (Cys); variable modifications, oxidation (Met); maximum
missed cleavages, 1; peptidemass tolerance, 20 ppm; MS/MS tolerance, 0.8 Da. Candidate pep-
tides were selectedwith probability-basedMowse scores that exceed the threshold, indicating
significant homology (p< 0.05; score over 20), and were referred to as “hits.” Precursor pep-
tides containing dimethylarginine residues were detected according to mass increases of 28 Da
from those of unmodifiedprecursor peptides.MS/MS spectra of dimethylated peptides were
manually assigned, and side-chain fragmentation of methylated arginine peptides was detected
as a neutral loss in MS/MS spectra to determine symmetric (31.04 Da) or asymmetric (45.05
Da) dimethylarginine levels [26, 32].
Polysome analysis
Cells were grown until they reached an OD600 of approximately 0.8. Then, they were harvested
and resuspended in mediumwith or without glucose for 20 min. Cultures were washed once
with lysis buffer containing 80 μg/mL cycloheximide, 200 μg/mL heparin, 10 mMTris-HCl
(pH 7.5), 0.1 M NaCl, 30 mMMgCl2, aprotinin and leupeptin and were then resuspended in
this lysis buffer. Glass beads were then added, and cells were broken by rigorous vortexing at
4°C (4 times at 2000 rpm for 30 s). Lysates were then centrifuged for 10 min at 15,000 g and
supernatants were collected. Sucrose gradients of 10%–50% were prepared in solutions con-
taining 1 mMDTT, 50 mMNH4Cl, 50 mMTris-Acetate (pH 7.0), and 12 mMMgCl2 using a
Gradient Station (Biocomp Laboratories Inc.). Lysates were added to sucrose gradients and
were centrifuged for 3 h at 27,000 rpm in a BeckmanCoulter centrifuge (Optima L-100K) at
4°C, followed by fractionation using an Incomparable Piston Gradient Fractionator and a Bio-
miniUVmonitor (Biocomp Laboratories Inc.). OD254 values were monitored to represent frac-
tionation results.
Statistical analysis
Data are presented as means ± standard deviations (SD) of at least three independent experi-
ments. Statistical analyses were performed using student’s t-test or analysis of variance
(ANOVA) followed by Tukey’s test and differences were considered significant when p< 0.05.
Results
Scd6 interacts with Hmt1
Scd6 is a translational repressor that reportedly interacts directly with eIF4G to block translation
initiation [8]. Scd6 is also known as a decapping activator that contributes to decapping com-
plexes of Scd6, Edc3, Pat1, and Dhh1 [10]. To identify other sets of proteins that associate with
Scd6 in cells, we performed yeast two-hybrid screening of yeast cDNA library using Scd6 as
bait. In addition to theDCP1 gene, which encodes a known Scd6-interactingpartner, DNA frag-
ments encodingHmt1 were recovered in these analyses. Other Scd6-interacting candidates are
listed in S3 Table. We also detected an interaction between Scd6 and Hmt1 in two-hybrid analy-
ses. Cells expressing both GBD-Scd6 and GAD-Hmt1 exhibited the His+ phenotype (Fig 1A).
Hmt1 is the major type I protein arginine methyltransferase (PRMT) in budding yeast and
catalyzes the production of both mono- and asymmetric di-methylarginines on histone and
Hmt1 Methylates Scd6
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non-histone proteins, especially RNA-binding proteins, and thereby regulates the functions
and localizations [20, 27]. Several RNA-binding proteins require mRNAs to associate with
other partners in the complex. Thus, to determine whethermRNA is required for the associa-
tion of Scd6 and Hmt1 in vivo, we performed co-immunoprecipitation with or without RNase
A treatment (Fig 1B). Immunoprecipitation of Scd6Flag from cell extracts with an anti-Flag
antibody led to coprecipitation of Hmt1myc, as detected using an anti-Myc antibody inWest-
ern blots. We also found that Hmt1 immunoprecipitated with Scd6 regardless of RNase A
treatment, suggesting that these proteins copurify in an RNA-independent manner. Subse-
quently, we performed in vitro binding assays using recombinant proteins to determine
Fig 1. Scd6 interacts with Hmt1. (A) Two-hybrid analysis; The yeast strain PJ69-4A was co-transformed
with pGBD-c1 or pGBD-c1-SCD6 with either pGAD-c1 or pGAD-c1-HMT1 and colonies were spotted onto
SC-Leu-Trp (WL) and SC-Leu-Trp-His (WLH) plates and incubated for 3 days at 30˚C. (B) Co-
immunoprecipitation analysis; Scd6Flag was immunoprecipitated from Hmt1myc strains harboring
YCplac33-SCD6FLAG or empty vector with an anti-Flag antibody, and were probed for Scd6Flag and
Hmt1myc using anti-Flag and anti-myc antibodies, respectively. Similar experiments were performed using
total extracts treated with RNase A prior to immunoprecipitation. (C) In vitro binding assays; His6-Hmt1 was
incubated with Glutathione sepharose beads that had been preloaded with equal amounts of GST or
GST-Scd6. Recombinant proteins were then detected using Coomassie staining and associated His6-Hmt1
was detected using an anti-His antibody.
doi:10.1371/journal.pone.0164773.g001
Hmt1 Methylates Scd6
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whether this interaction is direct or not. In these experiments, His6-Hmt1 was significantly
bound to GST-Scd6 (Fig 1C), indicating that the Hmt1–Scd6 interaction is direct, and may be
akin to enzyme and substrate interactions.
Scd6 contains asymmetrically methylated arginines in RGG motifs
Interactions were observedbetweenHmt1 and Scd6 in yeast two-hybrid, co-IP, and in vitro
binding assays, which suggested an enzyme–substrate interaction. PRMTs bind and methylate
RGG repeats in numerous RNA-binding proteins, and Scd6 contains RGG repeats in its car-
boxy-terminus [8, 21]. Accordingly, following immunoprecipitation of Scd6Flag from wild-
type and hmt1 cell lysates using a monoclonal anti-Flag antibody, we found that the Scd6Flag
band from hmt1 cells was slightly smaller than that from wild-type cells (Fig 2A), suggesting
that Hmt1 binds and methylates several arginine residues in RGGmotifs of Scd6.
To confirm this possibility and determinemodifications of Scd6, Scd6Flag from wild-type
and hmt1 cells were immunopurified as described above and were digested with chymotrypsin
in gels. Collectedpeptides were then analyzed using tandemmass spectrometry, and those con-
taining dimethyl arginine were compared. Chymotryptic peptides covering more than 80% of
entire protein sequence of Scd6 were detected (Fig 2B). Among these, four peptides contained
seven dimethyl arginines in RGGmotifs of Scd6 from wild-type cells, but not from hmt1 cells
(Fig 2B and 2C). Peptides containing aDMA or sDMA can be distinguished by neutral losses of
dimethylamine (m/z 45.05) and monomethylamine (m/z 31.04), respectively [26, 32]. Thus, we
assigned spectra to the peptide 277–290, which contains one aDMA (Fig 2D), and to the pep-
tide 298–313, which contains three aDMAs (Fig 2E). These results suggest that Scd6 is asym-
metrically dimethylated in the presence of Hmt1. Note that no significant differences were
observed for the associated proteins and RNAs in Scd6Flag-coimmunoprecipitates from wild-
type and hmt1 cells (S1 Fig).
Hmt1 regulates subcellular localization of Scd6 through arginine
methylation
Previous studies have shown that Npl3 and Hrp1 are involved in the export of bulk mRNA
from the nucleus and that Hmt1 is important for efficient export of these hnRNP complexes
[27]. Scd6 is a decapping activator and is accumulated in P-bodies under starvation conditions
[8]. Thus, we determinedwhether Scd6 localization is perturbed in hmt1 cells under conditions
of glucose deprivation. Scd6 was chromosomally tagged with the red fluorescent protein
mCherry in its C-terminus and colocalizationwith the P-body marker Edc3-GFPwas observed
in wild-type and hmt1 cells. We confirmed that Scd6-mCherry is still functional using scd6
dhh1 double mutant (data not shown). In wild-type cells, Scd6-mCherry foci were clearly
observedupon glucose deprivation and colocalizedwell with Edc3-GFP. In contrast, disruption
ofHMT1 significantly decreased foci formation of Scd6-mCherrywithout affecting Edc3-GFP
foci formation (Fig 3A and 3B). These data suggest that Hmt1 is required for targeting of Scd6
to P-bodies under stress conditions.
Argininemethylation by PRMTs is implicated in nucleocytoplasmic shuttling of some
hnRNPs [20], warranting further detailed analyses of the effects of arginine methylation on
Scd6 dynamics in granules. Observedmethylated arginine residues in Scd6 were substituted
with lysine (methylation deficient, Scd6RK) or phenylalanine (methylation mimic, Scd6RF)
[33], and were then visualized by taggingmRFP under glucose-deficient conditions. Under
these conditions, the percentage of the cells with Scd6RK-mRFP foci was decreased in compari-
son with those with Scd6WT-mRFP foci, and this was consistent with the defects observed in
hmt1mutant cells (Fig 3C and 3D). However, more severe defects of foci formation were
Hmt1 Methylates Scd6
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Fig 2. Arginine residues in RGG motifs of Scd6 are dimethylated in a Hmt1-dependent manner. (A)
Scd6Flag proteins from wild-type and hmt1 cells were immunoprecipitated using an anti-Flag antibody and
were separated using NU-PAGE gels, and were then visualized by immunoblotting with an anti-Flag
antibody. (B) Amino acid sequences of Scd6 are shown and chymotriptic peptides that were identified using
Tandem mass spectrometry analyses are indicated by underlines. Red letters indicate asymmetric
Hmt1 Methylates Scd6
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observedwith Scd6RF-mRFP. These results show that Hmt1-dependent arginine methylation
within the RGGmotifs of Scd6 is crucial for Scd6 accumulation in P-bodies under glucose-dep-
rivation conditions.
Scd6 is important for P-body accumulation
Scd6 was identified as a core component of P-bodies, along with Dhh1, Dcp2, and Edc3 [10],
and associations of these components are reportedly essential for P-body accumulation. Previ-
ous studies have shown that cells lacking Dhh1 have defective P-body formation [10].
Although percentages of cells with Dcp2-foci in scd6mutant cells under glucose starvation con-
ditions did not differ from those of wild-type cells, signal intensities of these granules in scd6
cells were lower than those in wild-type cells (Fig 4A). Detailed analyses of wild type cells using
linescan showed that foci with strong signal intensities were successfully formed under glucose
starvation conditions, but were significantly decreased in scd6 cells (P< 0.01, 0.68-fold). Addi-
tionally, Scd6 overexpression inducedmultiple distinct signals for P-bodies without inducing
stress (P< 0.01, 9.32-fold) compared to the cells with empty vector (Fig 4B). In contrast with a
previous study [10], overexpression of SCD6 using the 2μ-plasmid backbone did not lead to
growth phenotypes (S2 Fig). These results indicate that Scd6 plays important roles in the accu-
mulation of P-bodies.
Scd6 and Dhh1 have synthetic effects on cell growth and P-body
formation
Analyses of Scd6 physiological functions in vivowere restrained because the scd6mutation did
not affect growth under normal conditions. Thus, we performed genetic analyses to investigate
synthetic functions of Scd6 with components of decapping activators. In these analyses, genetic
interactions were identified between scd6 and dhh1 alleles. dhh1 scd6 double mutants showed
synthetic growth defects compared with those observed in dhh1 single mutants at 25°C (Fig
5A), and these growth defects becamemore severe at 37°C (Fig 5B), suggesting functional
redundancies of Scd6 and Dhh1 for cell growth.
As we and others have shown that both Scd6 and Dhh1 have function, in as much as some
extent, for P-body formation [7], scd6 dhh1 double mutant showed almost complete defect for
the formation of P-bodies under glucose starvation conditions (Fig 5C and 5D). These data
confirm the shared roles of Scd6 and Dhh1 that were observed in in vivo experiments, includ-
ing roles in P-body formation under stress conditions. Previously, global translation repression
and P-body formation were correlated under conditions of glucose deprivation [7]. Accord-
ingly, if Scd6 acts as a general translation repressor, defects in translation repression in scd6
dhh1 double mutants are likely correlated with defects in P-body formation. As a model of
global translational repression, glucose deprived cells exhibit declines in translation with poly-
some profiles [7, 9]. In the present study, wild-type and scd6 dhh1 cells were cultured in glu-
cose-containingmedium until the mid-log phase and were then subjected to glucose
deprivation prior to polysome analyses. Under glucose starvation conditions, scd6 dhh1 cells
showed similar reductions in polysome fractions to those observed in wild-type cells (S3 Fig),
dimethylarginines and residues of RGG motifs are shown in bold. (C) Chromatograms of four chymotryptic
peptides of Scd6 containing asymmetric dimethylarginines were compared between wild-type (upper panel)
and hmt1 cells (lower panel). Signal intensities of peptides were normalized to total ion current
chromatograms and ratios of signal intensities of peptides between wild-type and hmt1 cells are presented
as relative abundances of each peptide. NGSEVKDLSIL was used as an unmodified Scd6 peptide. (D, E)
MS/MS spectra of identified peptides containing asymmetric dimethylarginines; GQASARPRFHSRGL (D),
RGNRGNRGRGGQRGNY (E).
doi:10.1371/journal.pone.0164773.g002
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Fig 3. Hmt1 affected Scd6 subcellular localization. (A) Localization of Scd6-mCherry and Edc3-GFP;
Wild-type (WT) and hmt1 mutant cells carrying endogenous mCherry-tagged Scd6 were transformed with the
pRS314-EDC3-GFP plasmid. Cells were then grown to mid-log phase and were resuspended in medium
lacking glucose; Scale bar, 5 μm. (B) Percentages of more than 200 cells with Scd6-mCherry or Edc3-GFP
foci from three independent experiments are presented as means ± standard deviations (SD); *, P < 0.05. (C)
Scd6-mRFP localization; scd6 cells containing pRS316-SCD6-mRFP, pRS316-SCD6RF-mRFP, or
pRS316-SCD6RK-mRFP were grown and observed as in A. (D) Percentages of more than 200 cells with
Scd6-mRFP foci from three independent experiments are shown as means ± SD; *P < 0.05.
doi:10.1371/journal.pone.0164773.g003
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Fig 4. Scd6 plays roles in the accumulation of P-bodies. (A) Foci formation of Dcp2-GFP under glucose
depletion condition. Wild-type (WT) and scd6 mutant cells carrying endogenous Dcp2 tagged with GFP were
grown to mid-log phase and were resuspended in medium lacking glucose (-Glucose); Scale bar, 5 μm.
Percentages of cells with Dcp2-GFP foci among more than 200 cells from three independent experiments
are shown as means ± SD. Fluorescence intensities of Dcp2-GFP were measured using the linescan
Hmt1 Methylates Scd6
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function in MetaMorph, and fluorescence profiles are shown in the right panel. (B) Foci formation of
Dcp2-GFP in Scd6–overexpression condition. Dcp2-GFP cells harboring YEplac195 (2μ) or
YEplac195-SCD6 (2μ-SCD6) plasmids were grown to mid-log phase in glucose-containing medium
(+Glucose) as shown in A; *P < 0.05.
doi:10.1371/journal.pone.0164773.g004
Fig 5. Scd6 and Dhh1 have overlapping functions in cell growth and P-body formation. (A) Growth of
scd6 dhh1 mutant strain; Heterozygous strains carrying mutations in dhh1 and scd6 alleles were sporulated,
and tetrads were dissected onto YPD medium. Growth after 4 days at 25˚C is shown. (B) Growth assays;
Wild-type (WT), scd6, dhh1, and scd6 dhh1 mutant cells were spotted onto YPD medium and incubated at
25˚C or 37˚C. (C) Dcp2-GFP foci formation; Wild-type (WT), scd6, dhh1, and scd6 dhh1 cells in which
endogenous Dcp2 was tagged with GFP were grown in glucose-containing medium to the mid-log phase and
were then resuspended in medium lacking glucose; Scale bar, 5 μm. (D) Percentages of more than 200 cells
with Dcp2-GFP foci from three independent experiments are shown as means ± SD; **P < 0.01.
doi:10.1371/journal.pone.0164773.g005
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suggesting that overlapping cell growth and P-body formation functions of Scd6 and Dhh1
may not be related to global translation repression.
Arginine methylation regulates Scd6 function in relation to Dhh1
Since the scd6 dhh1 double mutants showed synthetic growth defects as described above, we
next investigated the genetic interaction between dhh1 and hmt1. Tetrad analysis revealved
that dhh1 single mutant grows slower than wild-type, and dhh1 hmt1 double mutant grows
much more slower than dhh1 single mutant, similarly to scd6 dhh1mutant. hmt1, scd6 and
scd6 hmt1mutants showed normal cell growth (Fig 6A). Thus, Hmt1 and Scd6may regulate
Dhh1-mediated cell growth in similar manners.
We determinedwhether Hmt1-dependent arginine methylation of Scd6 is involved in Scd6
and Dhh1 mediated regulation of cell growth. In these experiments (Fig 6B), expression of
wild-type Scd6 recovered cell growth in scd6 dhh1mutant cells at 25°C. Moreover, suppressive
effects of Scd6methylation-mimic and -deficient substitutions were indistinguishable from
wild-type cells at physiological temperature. In further experiments at 37°C, both wild-type
and methylation-deficient Scd6 suppressed cell growth, whereas methylation-mimic Scd6 did
not.
Under normal growth conditions, overexpression of methylation-mimic and -deficient Scd6
induced the formation of P-bodies to similar degrees as overexpressed wild-type Scd6 (Fig 6C
and 6D). No detectable differences in foci formation of Edc3-GFP or Dcp2-GFPwere observed
in hmt1mutant cells compared with that in wild-type cells under glucose starvation conditions
(Fig 3A and S4 Fig). Thus, our observations suggest that although arginine methylation of Scd6
by Hmt1 is essential for targeting of Scd6 to P-bodies, it is not required for cooperative contri-
butions of Scd6 and Dhh1 to the formation of P-bodies under physiological and stressed condi-
tions, such as glucose starvation. However, further studies are necessary to determine the
involvement of methylation in the regulation of Scd6 function following acute stress conditions
such as heat shock.
Discussion
Post-translational modifications are key regulators of signal transduction, protein–protein and
RNA–protein interactions, and of protein localizations. Herein, we showed that Scd6 associates
directly with Hmt1, the budding yeast homologue of human type I PRMT. Mass spectrometri-
cal analysis revealed that several arginine residues within the RGGmotif of Scd6 are methyl-
ated in a manner dependent on Hmt1. Arginine-methylation is required for P-bodies targeting
of Scd6, which is a decapping activator that functions in part with Dhh1.
P-body localization of Scd6 has been shown under conditions of glucose deprivation [8],
and previous studies suggest that P-bodies contain multiple proteins of mRNA decay [34]. The
present data show that Hmt1 binds and methylates Scd6. Hmt1 was previously shown to cata-
lyze arginine methylation of mRNP components with RGGmotifs such as Npl3, Sbp1, and
Ded1, which are reportedly localized in RNA granules [21]. In addition, the P-body component
Ebs1 [35] was recovered in our experiments, confirming the specificity of our screeningmeth-
ods, and Ebs1 was also recovered in proteomic analysis of Hmt1-TAP associating proteins
[36]. These observations suggest the presence of a functional link betweenHmt1 and compo-
nents of P-bodies [37].
Several arginine residues within the RGGmotif of Scd6 were methylated in a Hmt1 depen-
dent manner. Moreover, mass spectrometry analyses revealed the presence of aDMAs in Scd6
peptides from wild-type cells, and these modificationswere not observed in samples from
hmt1mutant cells. Although Scd6 was not recovered in proteomic analyses using a
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Fig 6. Hmt1 regulates Scd6 function. (A) Growth of scd6 hmt1 and dhh1 hmt1 mutant strains. Strains that
were heterozygous for scd6 hmt1 and dhh1 hmt1 were sporulated, and tetrads were dissected onto YPD
medium. Growth was determined after 4 days at 25˚C. (B) Growth assays; scd6 dhh1 mutant cells harboring
empty vector (empty) or plasmids containing wild-type, methylation-deficient (SCD6RK), or methylation-
mimic (SCD6RF) substitutions were spotted onto YPD medium and incubated at 25˚C or 37˚C. (C) scd6
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methylarginine antibody, the present data show heavy modifications of this protein in wild-
type cells. However, neither PRMT1 nor PRMT5 were recovered as interacting partners for
Scd6-homologs in mammalian cells, and only the aDMAmodificationwas detected in vitro
[26]. Hence, future assessments of degrees of methylation in individual RGG-motif containing
proteins and identification of responsible enzyme(s) may reveal functional and dynamic roles
of modifications of RGG-motif containing mRNP components.
Depletion of Hmt1 resulted in a specific targeting defect of Scd6 under conditions of glucose
depletion, whereas remarkable foci formation defects were not followed for other components
of P-bodies such as Dcp2 and Edc3. Similarly, methylation of mammalian RAP55A by PRMT1
specifically regulated localization to P-bodies without perturbing P-body formation or integrity
[26]. Thus, the regulatorymechanism for P-body targeting of Scd6 homologs following
PRMT1-dependent arginine methylation is widely conserved from yeast to mammals. In the
present experiments, Scd6 and Dhh1 additively promoted P-body formation independently of
Hmt1-mediated arginine methylation. Hence, mechanisms that lead to Scd6 accumulation in
P-bodies, and their regulation by Hmt1-dependent arginine methylation, remain uncharacter-
ized. Recent accumulating evidence indicates that Hmt1 methyltransferase activity is funda-
mental to protein functions and various molecular processes. In particular, following
interactions with Hmt1, Ccr4-Not complexes were involved in mRNA maturation and
Npl3-dependent nuclear export, and likely participated in cell-cycle progression by stabilizing
cyclin mRNA in response to environmental stimuli [38, 39]. Previous data suggest that Scd6 is
functionally involved in the activities of these Hmt1-targets. In particular, Scd6 and Npl3
played similar roles in the targeting of eIF4G for translation repression [8], and scd6 ccr4
mutant cells had more severe synthetic growth defects than ccr4mutant cells (data not shown).
Further studies are required to characterize the involvement of Scd6 in nuclear export of
mRNA, and to determine whether Hmt1 mediates the effects of Scd6 on cell cycle progression
as it does for Npl3 and Ccr4-Not.
Methylation-deficient mutation of Scd6 led to reduced granular-targeting of proteins com-
pared with wild-type proteins. However, methylation-mimic substitutions resulted in similar
effects. These substitutions may affect protein structure or associations of Scd6 with other com-
ponents such as Dhh1. Previously, PRMT1 depletion increased the association of RAP55A and
RCK/p54 (the homolog of Dhh1) [26]. Likewise, the present methylation-mimic Scd6 did not
suppress synthetic growth defects in dhh1 scd6mutant cells at elevated temperature (37°C),
whereas both methylation-deficient Scd6 and wild-type Scd6 did. Although, in the present
experiments, we were unable to identify specific conditions that affect the methylation status of
Scd6, our observationsmay suggest that stress-dependent regulation of Scd6 is due to
Hmt1-mediated methylation. Further analysis of post-translational modifications of mRNP
components and the corresponding regulatory roles under various stress conditions are
required to elucidate the functions and the structure of granules within cells.
Previous studies suggest that arginine methylation of RNA-binding proteins by PRMTs can
modulate binding affinities for RNAs, rather than protein–protein interactions of targets [20,
39]. However, no relevant changes in protein–protein interactions or RNA species were associ-
ated with the expression of Scd6Flag in wild-type and hmt1 cells. Thus, arginine methylation of
Scd6may contribute to mRNA target specificity rather than to general associations of Scd6
Dcp2-GFP cells harboring YCplac33 (CEN) or YEplac195 (2μ) plasmids containing wild-type (SCD6),
methylation-deficient (SCD6RK), or methylation-mimic (SCD6RF) substitutions were grown to mid-log phase
in glucose-containing medium (+Glucose); Scale bar, 5 μm. (D) Percentages of Dcp2-GFP foci among more
than 200 cells from three independent experiments are shown as means ± SD; *P < 0.05.
doi:10.1371/journal.pone.0164773.g006
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with RNAs or protein partners. However, to validate these hypotheses, specificmRNA targets
of Scd6 need to be identified, and the effects of Hmt1-mediated arginine methylation on speci-
ficity need to be analyzed. A set of Scd6-precipitatedmRNAs was submitted to the Gene
Expression Omnibus (GEO) by Dan Klass in 2010. These data show that mRNAs that are tran-
scribed from sub-telomeric regions, and codingmRNAs for proteins of telomere capping
maintenance and/or DNA replication, were substantially accumulated in Scd6-precipitates.
Because proteins for DNA replication stress responses could also be targeted to P-bodies, it will
be of interest to determine whether Hmt1 regulates Scd6 targeting to P-bodies under these
stress conditions.
In summary, we provide evidence of important roles of Scd6 with Dhh1 in the formation of
P-bodies and cell growth, particularly under stress conditions. Specifically, Hmt1 associates
with Scd6 to facilitate arginine methylation, leading to efficient targeting of Scd6 to P-bodies.
Whether the present post-translational modifications, such as arginine methylation, offer com-
mon mechanisms that facilitate the dynamics of mRNP components under stress conditions
remains to be clarified.
Supporting Information
S1 Fig. No remarkable changes were observed for Scd6Flag associatedproteins and RNAs
in wild-typeand hmt1 cells. (A) Colloidal Blue staining of Scd6Flag immunoprecipitates;
Scd6Flag proteins from wild-type and hmt1 cells were immunoprecipitated using an anti-Flag
antibody and were separated using SDS-PAGE gels followed by Colloidal blue staining. (B)
PurifiedRNAs from Scd6Flag immunoprecipitates; Scd6Flag proteins were immunoprecipi-
tated using an anti-Flag antibody. RNA species, which were purified from those Scd6Flag
immunoprecipitates, were subjected to UREA-PAGE followed by SYBR-Gold staining.
(TIF)
S2 Fig. Scd6 overexpression does not affect cell growth.Growth assays; Cells containing indi-
cated plasmids were spotted onto SC medium lacking uracil (SC-Ura) and were incubated at
30°C.
(TIF)
S3 Fig. Scd6 was not essential for general translation repression under glucose starvation
conditions.Wild-type (WT) and scd6 dhh1 cells were grown in rich medium (+Dex) and were
subjected to glucose deprivation (-Dex) and typical polysome profiles (OD254 traces) are pre-
sented. Small and large ribosomal subunits (40S and 60S, respectively), monosomes (80S), and
polysomes are labeled.
(TIF)
S4 Fig. P-body formation is not affected byHMT1 discruption.Dcp2-GFP foci formation;
Wild-type and hmt1 cells expressing Dcp2-GFPwere grown to mid-log phase and resuspended
into medium lacking glucose.
(TIF)
S1 Table. Strains used in this study.
(PDF)
S2 Table. Plasmids used in this study.
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S3 Table. Results of Yeast two-hybrid screening.
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